戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1  underlie vHPC lesion-induced behavioral DA 'supersensitivity'.
2 secretion by residual axons, and denervation supersensitivity.
3 as higher expression resulted in the loss of supersensitivity.
4  mouse models of psychostimulant or dopamine supersensitivity.
5 echanism contributes to central dopaminergic supersensitivity.
6 be responsible for the development of D(2)DR supersensitivity.
7 ion may be an underlying cause of behavioral supersensitivity.
8 nists due to the development of postsynaptic supersensitivity.
9  were accompanied by dopamine D2/D3 receptor supersensitivity.
10 urse reminiscent of experimental denervation supersensitivity.
11 se fat pads and results in vagal denervation supersensitivity.
12 ed vasoconstriction and possible denervation supersensitivity.
13                                     Receptor supersensitivity accounts for some but not all aspects o
14 ture of CRPS I, we investigated whether this supersensitivity also occurs in the sudomotor system.
15 t elimination of GRK5 results in cholinergic supersensitivity and impaired muscarinic receptor desens
16 riety of phenotypes were observed, including supersensitivity and resistance to the microtubule-desta
17 way that enhance this RO-specific DNA damage supersensitivity by promoting ectopic recombination betw
18 the development and expression of behavioral supersensitivity compared to rats treated with quinpirol
19 avioral phenotypes that includes amphetamine supersensitivity, hyperexploratory behavior and rotarod
20                                 The dopamine supersensitivity hypothesis cannot account for the time
21  evidence is cited for a form of denervation supersensitivity in causalgia and for increased expressi
22                         alpha-Adrenoreceptor supersensitivity in many tissues has been described in p
23 rsed by L-DOPA and evidence of "dopaminergic supersensitivity" in the striatum.
24 ng the well described phenomenon of dopamine supersensitivity indicating that apomorphine not only re
25  tub3Delta, supporting the idea that benomyl supersensitivity is a rough measure of microtubule insta
26 induction of IEGs, that D1 dopamine receptor supersensitivity is attributable to a switch to ERK1/2/M
27 sure exerted by paclitaxel binding, and drug supersensitivity is lost.
28                                         This supersensitivity is reversed when CRPS I resolves.
29 an axon reflex and that alpha-adrenoreceptor supersensitivity occurs in the presynaptic portion of th
30        The time course of fluoxetine-induced supersensitivity of hypothalamic 5-HT2A/2C receptors was
31 posed to levodopa, and these may result from supersensitivity of postsynaptic striatal dopamine D1 an
32    In vitro calcineurin digestion shows that supersensitivity of S603 dephosphorylation is an inheren
33  homeostasis are accompanied by a pronounced supersensitivity of the mice to the locomotor effects of
34                        It is understood that supersensitivity of the striatonigral pathway underlies
35  of sympathetic neurotransmission, selective supersensitivity of the vascular smooth muscle to sympat
36 ression of AtRGS1 complemented the pheromone supersensitivity phenotype of a yeast RGS mutant, sst2De
37 in had a thermal instability and phosphatase supersensitivity similar to that of the A638 and E638 mu
38 uples Gpa1p from Sst2p, results in pheromone supersensitivity similar to the sst2 mutant, and promoti
39 malization of striatal dopaminergic receptor supersensitivity than wild-type grafts.
40  cyclase responses instead of displaying the supersensitivity that had been seen in the young group.
41 was present in only 1 patient, and pupillary supersensitivity to 2.5% phenylephrine was not observed.
42 owing that purine synthesis inhibitors cause supersensitivity to A. tumefaciens transformation in thr
43 ne auxotrophs were identified that exhibited supersensitivity to A. tumefaciens-mediated transformati
44 These findings support a model of cerebellar supersensitivity to alcohol-related tissue volume defici
45 C-3 and melanoma cell line A375-C6 conferred supersensitivity to apoptotic stimuli.
46 sed dispersion of action potential duration, supersensitivity to beta-adrenergic receptor stimulation
47                                         This supersensitivity to dephosphorylation in vitro was also
48 n growth rate, they demonstrate an intrinsic supersensitivity to DNA-damaging agents.
49 tients with endothelial dysfunction and that supersensitivity to exogenous nitrates is not clinically
50 ted vegetative growth and rescued cells from supersensitivity to fluoride, but homozygous diploids fa
51                  In addition to the striatal supersensitivity to induction of the permeability transi
52 oportion to its abundance and thereby caused supersensitivity to microtubule disruptive drugs such as
53              Low expression of beta4a caused supersensitivity to paclitaxel, whereas higher expressio
54 tant exhibits a synergistic, or "synthetic," supersensitivity to pheromone.
55                        Mice lacking PRs show supersensitivity to the antiseizure responses of progest
56 lay enhanced filamentous differentiation and supersensitivity to the MAPK signal.
57 tation of oxytocin neurones does not involve supersensitivity to the noradrenergic input, or hypersen
58 hypothermia as well as pronounced behavioral supersensitivity upon challenge with the nonselective mu
59 gic interneurons in situ could contribute to supersensitivity without receptor upregulation.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。